These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23665803)

  • 21. Consensus report on the future of animal-free systemic toxicity testing.
    Leist M; Hasiwa N; Rovida C; Daneshian M; Basketter D; Kimber I; Clewell H; Gocht T; Goldberg A; Busquet F; Rossi AM; Schwarz M; Stephens M; Taalman R; Knudsen TB; McKim J; Harris G; Pamies D; Hartung T
    ALTEX; 2014; 31(3):341-56. PubMed ID: 25061899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Summary: EU standards measurements and testing project PL95-3407. Development of a standardised in vitro methodology for hepatic and renal toxicity testing.
    Hartung T
    Altern Lab Anim; 2001; 29(4):493-5. PubMed ID: 11565511
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanistic validation.
    Hartung T; Hoffmann S; Stephens M
    ALTEX; 2013; 30(2):119-30. PubMed ID: 23665802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
    Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
    Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspective.
    Sewell F; Aggarwal M; Bachler G; Broadmeadow A; Gellatly N; Moore E; Robinson S; Rooseboom M; Stevens A; Terry C; Burden N
    Toxicology; 2017 Aug; 389():109-117. PubMed ID: 28774667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives on validation of high-throughput assays supporting 21st century toxicity testing.
    Judson R; Kavlock R; Martin M; Reif D; Houck K; Knudsen T; Richard A; Tice RR; Whelan M; Xia M; Huang R; Austin C; Daston G; Hartung T; Fowle JR; Wooge W; Tong W; Dix D
    ALTEX; 2013; 30(1):51-6. PubMed ID: 23338806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing in vivo, in vitro and in silico methods and integrated strategies for chemical assessment: problems and prospects.
    Benfenati E; Gini G; Hoffmann S; Luttik R
    Altern Lab Anim; 2010 May; 38(2):153-66. PubMed ID: 20507186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using toxicological evidence from QSAR models in practice.
    Benfenati E; Pardoe S; Martin T; Gonella Diaza R; Lombardo A; Manganaro A; Gissi A
    ALTEX; 2013; 30(1):19-40. PubMed ID: 23338804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicology is IN: in silico, in vitro, integrated testing strategy.
    Caloni F; Benfenati E; Sambuy Y
    ALTEX; 2016; 33(2):187-8. PubMed ID: 27032091
    [No Abstract]   [Full Text] [Related]  

  • 30. Three Rs Approaches in Marine Biotoxin Testing. The Report and Recommendations of a joint ECVAM/DG SANCO Workshop (ECVAM Workshop 54).
    Hess P; Grune B; Anderson DB; Aune T; Botana LM; Caricato P; van Egmond HP; Halder M; Hall S; Lawrence JF; Moffat C; Poletti R; Richmond J; Rossini GP; Seamer C; Vilageliu JS;
    Altern Lab Anim; 2006 May; 34(2):193-224. PubMed ID: 16704292
    [No Abstract]   [Full Text] [Related]  

  • 31. Limitations and uncertainties of acute fish toxicity assessments can be reduced using alternative methods.
    Paparella M; Scholz S; Belanger S; Braunbeck T; Bicherel P; Connors K; Faßbender C; Halder M; Lillicrap A; Liska R; Schirmer K; Stoddart G; Thomas P; Walter-Rohde S
    ALTEX; 2021; 38(1):20-32. PubMed ID: 32970822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steps towards the international regulatory acceptance of non-animal methodology in safety assessment.
    Sewell F; Doe J; Gellatly N; Ragan I; Burden N
    Regul Toxicol Pharmacol; 2017 Oct; 89():50-56. PubMed ID: 28689746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The patchwork of toxicological research for pharmaceutical testing.
    von Aulock S
    ALTEX; 2010; 27(1):1. PubMed ID: 20397314
    [No Abstract]   [Full Text] [Related]  

  • 34. Performance standards and alternative assays: practical insights from skin sensitization.
    Kolle SN; Basketter DA; Casati S; Stokes WS; Strickland J; van Ravenzwaay B; Vohr HW; Landsiedel R
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):278-85. PubMed ID: 23279805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. REACH, non-testing approaches and the urgent need for a change in mind set.
    Schaafsma G; Kroese ED; Tielemans EL; Van de Sandt JJ; Van Leeuwen CJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):70-80. PubMed ID: 19061930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An International Perspective on the Tools and Concepts for Effluent Toxicity Assessments in the Context of Animal Alternatives: Reduction in Vertebrate Use.
    Norberg-King TJ; Embry MR; Belanger SE; Braunbeck T; Butler JD; Dorn PB; Farr B; Guiney PD; Hughes SA; Jeffries M; Journel R; Lèonard M; McMaster M; Oris JT; Ryder K; Segner H; Senac T; Van Der Kraak G; Whale G; Wilson P
    Environ Toxicol Chem; 2018 Nov; 37(11):2745-2757. PubMed ID: 30359486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Workshop on acceleration of the validation and regulatory acceptance of alternative methods and implementation of testing strategies.
    Piersma AH; Burgdorf T; Louekari K; Desprez B; Taalman R; Landsiedel R; Barroso J; Rogiers V; Eskes C; Oelgeschläger M; Whelan M; Braeuning A; Vinggaard AM; Kienhuis A; van Benthem J; Ezendam J
    Toxicol In Vitro; 2018 Aug; 50():62-74. PubMed ID: 29501630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expert opinions on the acceptance of alternative methods in food safety evaluations: Formulating recommendations to increase acceptance of non-animal methods for kinetics.
    Punt A; Bouwmeester H; Schiffelers MWA; Peijnenburg AACM
    Regul Toxicol Pharmacol; 2018 Feb; 92():145-151. PubMed ID: 29196030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-animal approaches for toxicokinetics in risk evaluations of food chemicals.
    Punt A; Peijnenburg AACM; Hoogenboom RLAP; Bouwmeester H
    ALTEX; 2017; 34(4):501-514. PubMed ID: 28403478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.